Orange Book product · Generic (ANDA)
BUMETANIDE
BUMETANIDE
At a glance
Apr 30, 2018
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 30, 2018
8 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
BUMETANIDE
Strength
0.5MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 202900
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BUMETANIDE
- 2025ENBUMYSTBrand (NDA)
NDA 219500 · CORSTASIS THERAP
- 1983BUMEXBrand (NDA)
NDA 018226 · VALIDUS PHARMS
- 1983BUMEXBrand (NDA)
NDA 018225 · VALIDUS PHARMS
- 2026BUMETANIDEGeneric (ANDA)
ANDA 220427 · ANTHEA PHARMA
- 2026BUMETANIDEGeneric (ANDA)
ANDA 215362 · MSN
- 2025BUMETANIDEGeneric (ANDA)
ANDA 212470 · JUBILANT GENERICS
- 2025BUMETANIDEGeneric (ANDA)
ANDA 219291 · MANKIND PHARMA
- 2025BUMETANIDEGeneric (ANDA)
ANDA 218746 · ASPIRO
- 2024BUMETANIDEGeneric (ANDA)
ANDA 213942 · RUBICON RESEARCH
- 2024BUMETANIDEGeneric (ANDA)
ANDA 219116 · QILU PHARM HAINAN
- 2024BUMETANIDEGeneric (ANDA)
ANDA 212931 · APPCO
- 2024BUMETANIDEGeneric (ANDA)
ANDA 217153 · LUPIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
